Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars
16-May-2018 -
Catalent Pharma Solutions and Valerius Biopharma AG, a Swiss biopharmaceutical company dedicated to providing interchangeable treatment options for high-priced orphan and non-orphan biologics, announced that they are to collaborate on the development and manufacture of Valerius’ biosimilar ...
biosimilars
feasibility studies
recombinant proteins